GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II‐mediated pressor responses in Sprague–Dawley rats
- 1 June 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 151 (4), 450-456
- https://doi.org/10.1038/sj.bjp.0707241
Abstract
Liver X receptors (LXRs) activate genes that regulate lipid and cholesterol metabolism. LXR agonists were shown recently to also increase murine renin gene expression in vivo. To further examine a link between lipid metabolism, the renin-angiotensin-aldosterone-system and blood pressure regulation, we investigated the effect of a LXR agonist (GW3965) on angiotensin II (Ang II)-mediated vasoreactivity and vascular angiotensin II receptor (ATR) gene expression. Arterial blood pressure (BP) was measured during Ang II infusions (1.5 min duration; 0.001-3 microg kg(-1)) in pentobarbital-anesthetized male Sprague-Dawley rats (n = 6-9) after oral administration of GW3965 (10 mg kg(-1), q.d.) or vehicle for 7 - 15 days. Mesenteric arteries and plasma were collected to analyze ATR gene expression and to measure plasma renin activity (PRA) and lipid profile, respectively. Basal mean arterial pressure (MAP) was similar between groups. GW3965 dosing blunted the vasopressor effect of Ang II, which was significantly different with the 0.3 and 3 microg kg(-1) doses. No difference in heart rate, PRA or lipid profile was observed between groups. A time-course indicated that ATR type 1 and 2 gene expression of GW3965-treated vs. vehicle-treated rats decreased by 50%, reaching significance for ATR type 2, but not for ATR type 1, at time-points coinciding with BP measurements. GW3965 decreased Ang II-mediated vasopressor responses coincident with a trend toward reduced ATR gene expression, suggesting that LXR agonists could affect vascular reactivity.This publication has 27 references indexed in Scilit:
- Liver X receptors as integrators of metabolic and inflammatory signalingJCI Insight, 2006
- Liver X receptors and regulate renin expression in vivoJCI Insight, 2005
- Liver X receptor agonists inhibit tissue factor expression in macrophagesThe FEBS Journal, 2005
- Phospholipid Transfer Protein Is Regulated by Liver X Receptors in VivoPublished by Elsevier BV ,2002
- Central role of the AT1-receptor in atherosclerosisJournal of Human Hypertension, 2002
- Structure, Endothelial Function, Cell Growth, and Inflammation in Blood Vessels of Angiotensin II–Infused RatsCirculation, 2002
- Regulation of Lipoprotein Lipase by the Oxysterol Receptors, LXRα and LXRβPublished by Elsevier BV ,2001
- Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR elementJCI Insight, 2000
- Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRαCell, 1998
- An oxysterol signalling pathway mediated by the nuclear receptor LXRαNature, 1996